Source link : https://www.newshealth.biz/health-news/endo-2024-roundup-teen-glp-1-coverage-novel-cah-drug-hot-flash-risks/
BOSTON — Some of the latest research advancements in hormonal health presented at the Endocrine Society’s ENDO 2024 included a daily male birth control gel, semaglutide’s taste sensitivity-boosting properties, and a novel drug for congenital adrenal hyperplasia (CAH). Below are some more scientific highlights from this year’s meeting. Coverage for Teen GLP-1 Users Insurance coverage […]
Author : News Health
Publish date : 2024-06-05 20:42:18
Copyright for syndicated content belongs to the linked Source.
Categories